Wolf SBarton DKottschade L. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 2008;44:1507–1515.
Seretny MCurrie GLSena ES. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 2014;155:2461–2470.
Park SBGoldstein DKrishnan AV. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 2013;63:419–437.
Kneis SWehrle AFreyler K. Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy. Clin Neurophysiol 2016;127:1481–1490.
Monfort SMPan XPatrick R. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat 2017;164:69–77.
Wampler MATopp KSMiaskowski C. Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy. Arch Phys Med Rehabil 2007;88:1002–1008.
Miaskowski CMastick JPaul SM. Chemotherapy-induced neuropathy in cancer survivors. J Pain Symptom Manage 2017;54:204–218.
Winters-Stone KMHorak FJacobs PG. Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 2017;35:2604–2612.
McCrary JMGoldstein DBoyle F. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Support Care Cancer 2017;25:3485–3493.
Alberti PRossi ECornblath DR. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol 2014;25:257–264.
Stout NL. Expanding the perspective on chemotherapy-induced peripheral neuropathy management. J Clin Oncol 2017;35:2593–2594.
Maki BEHolliday PJTopper AK. A prospective study of postural balance and risk of falling in an ambulatory and independent elderly population. J Gerontol 1994;49:M72–84.
Sturnieks DLArnold RLord SR. Validity and reliability of the Swaymeter device for measuring postural sway. BMC Geriatr 2011;11:63.
Lord SRMenz HBTiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003;83:237–252.
Panzer VPWakefield DBHall CB. Mobility assessment: sensitivity and specificity of measurement sets in older adults. Arch Phys Med Rehabil 2011;92:905–912.
Wallmann HW. Comparison of elderly nonfallers and fallers on performance measures of functional reach, sensory organization, and limits of stability. J Gerontol A Biol Sci Med Sci 2001;56:M580–583.
Lord SRWard JA. Age-associated differences in sensori-motor function and balance in community dwelling women. Age Ageing 1994;23:452–460.
Lord SRClark RDWebster IW. Physiological factors associated with falls in an elderly population. J Am Geriatr Soc 1991;39:1194–1200.
Lord SRWard JAWilliams P. Physiological factors associated with falls in older community-dwelling women. J Am Geriatr Soc 1994;42:1110–1117.
Cornblath DRChaudhry VCarter K. Total neuropathy score: validation and reliability study. Neurology 1999;53:1660–1664.
Postma TJAaronson NKHeimans JJ. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 2005;41:1135–1139.
Binda DVanhoutte EKCavaletti G. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). Eur J Cancer 2013;49:2910–2918.
Tiedemann AShimada HSherrington C. The comparative ability of eight functional mobility tests for predicting falls in community-dwelling older people. Age Ageing 2008;37:430–435.
Schwartz AVHillier TASellmeyer DE. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002;25:1749–1754.
Brouwers EEHuitema ADBoogerd W. Persistent neuropathy after treatment with cisplatin and oxaliplatin. Acta Oncol 2009;48:832–841.
Kus TAktas GKalender ME. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study. Support Care Cancer 2016;24:1175–1179.
Peters EMendoza Schulz LReuss-Borst M. Quality of life after cancer-how the extent of impairment is influenced by patient characteristics. BMC Cancer 2016;16:787.
Huang MHBlackwood JGodoshian M. Prevalence of self-reported falls, balance or walking problems in older cancer survivors from Surveillance, Epidemiology and End Results-Medicare Health Outcomes Survey. J Geriatr Oncol 2017;8:255–261.
- Search Google Scholar
- Export Citation
)| false . , Huang MH , Blackwood J , Godoshian M Prevalence of self-reported falls, balance or walking problems in older cancer survivors from Surveillance, Epidemiology and End Results-Medicare Health Outcomes Survey. 2017; 8: 255– 261. 28602712 10.1016/j.jgo.2017.05.008
Huang MHLytle TMiller KA. History of falls, balance performance, and quality of life in older cancer survivors. Gait Posture 2014;40:451–456.
Griffith KADorsey SGRenn CL. Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. J Peripher Nerv Syst 2014;19:127–135.
- Search Google Scholar
- Export Citation
)| false . , Griffith KA , Dorsey SG , Renn CL Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. 2014; 19: 127– 135. 10.1111/jns5.12064 24814100
Lord SRClark RDWebster IW. Postural stability and associated physiological factors in a population of aged persons. J Gerontol 1991;46:M69–76.
Horlings CGvan Engelen BGAllum JH. A weak balance: the contribution of muscle weakness to postural instability and falls. Nat Clin Pract Neurol 2008;4:504–515.